Profiel
Xavier Avat, former Head of Corporate Development at Gilead Sciences, Inc., served as the SVP of Global Corporate Strategy & New Initiatives at Edwards Lifesciences Corp.
He also held the position of Vice President of Corporate Development at Santen Pharmaceutical Co., Ltd.
In 2022-2023, Avat worked as the Chief Business Officer at Capricor Therapeutics, Inc. Avat graduated from Ecole Polytechnique Universitaire de Lille and holds an MBA from École des Hautes Études Commerciales du Nord.
Eerdere bekende functies van Xavier Avat
| Bedrijven | Functie | Einde |
|---|---|---|
| CAPRICOR THERAPEUTICS, INC. | Corporate Officer/Principal | 01-04-2023 |
| GILEAD SCIENCES, INC. | Corporate Officer/Principal | - |
| SANTEN PHARMACEUTICAL CO., LTD. | Corporate Officer/Principal | - |
| EDWARDS LIFESCIENCES CORPORATION | Corporate Officer/Principal | - |
Opleiding van Xavier Avat
| École des Hautes Études Commerciales du Nord | Masters Business Admin |
| Ecole Polytechnique Universitaire de Lille | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 4 |
|---|---|
| CAPRICOR THERAPEUTICS, INC. | Health Technology |
| EDWARDS LIFESCIENCES CORPORATION | Health Technology |
| SANTEN PHARMACEUTICAL CO., LTD. | Health Technology |
| GILEAD SCIENCES, INC. | Health Technology |